CAS: 76-19-7; Octafluoropropane

该化合物是属于全氟碳化物(PFCs)类别的完全氟化的碳氢化合物,其特点是三颗碳原子,每个原子完全饱和氟原子,形成C3F8的化学配方.这种化合物在室温和压力下是一种无色,无味的气体,由于碳-氟联结的强度,具有高度稳定性.全氟丙烷不易燃,毒性较低,因此对各种应用来说相对安全.其独特特性包括高密度和低沸点,有助于将其用作制冷剂和各种工业应用,包括医疗成像中的对比剂.此外,全氟丙烷的温室气体潜力值得注意,尽管它与其他全氟碳化物相比在大气中不太普遍,但其环境影响是正在进行的研究的主题,特别是其持久性和对气候变化的潜在影响.

结构式图片

欧盟法规

REACH注册ECHA物质ECHA物质C&L通报REACH预注册

上下游产品

CAS号422-04-8 pentafluoroprop... | CAS号71-43-2 苯 | CAS号116-15-4 六氟丙烯 | CAS号463-49-0 丙二烯 | CAS号116-14-3 四氟乙烯 | CAS号75-10-5 二氟甲烷 | CAS号34557-54-5 methane | CAS号75-46-7 三氟甲烷 | CAS号754-34-7 全氟丙基碘 | CAS号422-85-5 七氟丙基溴 | CAS号75-63-8 三氟溴甲烷 | CAS号354-55-2 溴五氟乙烷 | CAS号116-15-4 六氟丙烯 | CAS号76-16-4 六氟乙烷 | CAS号382-21-8 全氟异丁烯 | CAS号354-33-6 五氟乙烷 | CAS号75-10-5 二氟甲烷 | CAS号75-46-7 三氟甲烷 | CAS号56112-35-7 2,3,3,3-tetrafl...

合成工艺路线路线简述

  • 合成目标产物 Perfluoropropane 主要起始原料 Hexafluoropropylene
  • (文献来源)合成步骤主要原料 Hexafluoropropylene
苯置于铜,Fluorine体系中,化学反应生成 八氟丙烷
参考文献:Fukuhara; Bigelow,Journal Of The American Chemical Society,1941,Vol. 63,P. 2793
标题:Fukuhara; Bigelow,Journal Of The American Chemical Society,1941,Vol. 63,P. 2793

海关参考信息

专利信息


专利号:US-2004038331-A1
优先权日:2002-08-23
标题:Solid phase synthesis of biomolecule conjugates
发明人:REDDY M PARAMESWARA; FAROOQUI FIRDOUS; BRILLHART KURT L
摘要:Processes for the solid state phase formation synthesis of biomolecule conjugates, particularly protein-oligonucleotide conjugates are shown. One of the protein or oligonucleotide is reversibly bound to a solid substrate phase. At least one portion of each of the protein and the oligonucleotide molecules is activated with complementary activation groups. The activated protein and the activated oligonucleotide are then reacted, in a buffered solution resulting in the formation of the desired conjugate which remains reversibly bound to the substrate. The nature of the buffered solution is then modified causing the conjugate to be released from the substrate solid phase.

专利号:US-2010173100-A1
优先权日:2006-01-16
标题 :Method for the synthesis of product molecules
发明人:WEISS HORST; GERBER GUSTAV; NUERNBERGER PATRICK HENNING; WOLPERT DANIEL STEPHAN
权利人:BASF AG
摘要:The invention relates to a method for the synthesis of product molecules, wherein ultrashort laser pulses shaped with the aid of a pulse shaper are generated and a gas which contains educt molecules is fed onto a surface, on which the educt molecules are at least partially adsorbed, the shaped ultrashort laser pulses being directed onto the surface in order to control a reaction process for synthesis of the product molecules from educts adsorbed on the surface.

专利号:WO-9010069-A1
优先权日:1989-02-28
标题:RECOMBINANT PLASMID DNA pAA 1213-23 AND pAC 262-33 CODING FOR SYNTHESIS OF HUMAN INTERLEUKIN-2, METHOD OF THEIR CONSTRUCTION AND STRAIN OF BACTERIA ESCHERICHIA COLI RRI/pAC 262-33 AS PRODUCER OF HUMAN INTERLEUKIN-2
发明人:AVOT ANDRIS YANOVICH; VARIVOTSKAYA NADEZHDA VIKTOROV; VOITENOK NIKOLAI NIKOLAEVICH; GREN ELMAR YANOVICH; MARTINOVICH ALEXANDR EVGENIEVI; ROMANCHIKOVA NADEZHDA VIKTOROV; SEVCH NINA VYACHESLAVOVNA; TSIMANIS ALEXANDR JURIEVICH; APSALON ULDIS RUDOLFOVICH; BUNDULIS JURIS PETROVICH; LUNEV VITALY EVGENIEVICH; ONOPRIENKO LJUDMILA VIKTOROVNA; SKRIVELIS VITALY ANDRISOVICH
权利人:INST ORGANICHESKOGO SINTEZA AK
摘要:A recombinant plasmid DNA pAA 1213-23 coding for synthesis of human interleukin-2 has a size of 5,150 b.p. and consists of the following elements: an EcoRI-SalI fragment, of a size of 3,710 b.p. of vector plasmid pBR 322; a Cfr 13 fragment of a size of 880 b.p. containing a promoter of tryptophan operon, a polylinker section of recognition of restrictase EcoRI, SmaI, BamHI, initiating ATG and first GCC codons of mature interleukin-2; a Cfr 13-SalI fragment of a size of 570 b.p. of cloned cDNA. A recombinant plasmid DNA pAC 262-33 on the basis of said DNA pAA 1213-23 has a size of 5,135 b.p. and consists of the following elements: an EcoRI-SalI fragment of a size of 3,710 b.p. of vector plasmid pBR 322; a Cfr 13 fragment of a size of 867 b.p.; a Cfr 13-SalI fragment of a size of 570 b.p. of cloned cDNA. A method of construction of recombinant plasmid DNA pAC 262-33 comprises the preliminary construction of plasmid DNA pAA 1213-23 with subsequent construction, on its basis, of plasmid pAC 262-33 with a changed distance between the Shine-Dalgarno sequence and the initiating ATG codon. A strain Escherichia coli RRI/pAC 262-33 as producer of interleukin-2 deposited on 10.07.87 under No VKPM B-3823 at the USSR-Union Collection of Industrial Microorganisms of the USSR Research Institute for Genetics and Industrial Microorganisms Breeding.

专利号:US-9731284-B1
优先权日:2014-03-24
标 题:Process for oxidation of amines in the synthesis of energetic materials
发明人:SANCHEZ PEGGY A; GRISWOLD KIMBERLY; GORUN SERGIU M; PATEL HEMANTBHAI H
权利人:US ARMY; SETON HALL UNIV
摘要:A process for use of composite catalysts for oxidation of amines during synthesis of energetic compounds. This method overcomes the safety concerns associated with dangerous reaction conditions for these energetic materials. The process requires exposing phthalocyanine conjugated to an inorganic substrate to the precursor reactant and activating the composite material to light and oxygen to covert amine groups into oxidized nitrogen species.

专利号:EP-2676962-A1
优先权日:2012-06-21
标 题 :Derivatives of 1-aminoalkylphosphonate diaryl esters, method of 1-aminoalkylphosphonate diaryl ester derivatives preparation and their application
发明人:SIENCZYK MARCIN; GRZYWA RENATA; PIETRUSEWICZ EWA; OLEKSYSZYN JOZEF; WINIARSKI LUKASZ; BURSTER TIMO; BOEHM OTTO
权利人:UNIV ULM; WROCLAW UNIVERSITY OF TECHNOLOGY
摘要:The subject of the invention relates to 1-aminoalkylphosphonate diaryl esters of formula I, in which Bt represents biotin, W is a hydrocarbon linker chain of 5 to 10 carbon atoms, Y is the amino acid residues in an amount of 0 to 4, R is a substituent corresponding to the side chain of valine, alanine, leucine, phenylalanine, 4-guanidinephenylglycine, or 2-aminobutyric acid (Abu), X is the hydrogen or a compound selected from the group consisting of mercaptomethyl (S-methyl), methoxy (O-methyl), or carboxymethyl, and their use as inhibitors of serine proteases, and the low molecular weight molecular probes to detect the catalytically active forms of the enzymes. n A process for preparing 1-aminoalkylphosphonate diaryl esters of formula I, in which Bt represents biotin, W is a hydrocarbon linker chain of 5 to 10 carbon atoms, Y is the amino acid residues in an amount of 0 to 4, R is a substituent corresponding to the side chain of valine, alanine, leucine, phenylalanine, 4-guanidinephenylglycine, or 2-aminobutyric acid (Abu), X is the hydrogen or a compound selected from the group consisting of mercaptomethyl (S-methyl), methoxy (O-methyl), or carboxymethyl relies on application of triaryl phosphite, obtained from the phenol substituted at para position phosphorus (III) chloride in refluxing acetonitrile and is subjected to amidoalkylation reaction with benzyl carbamate and an aldehyde such as acetaldehyde, propionic aldehyde, iso -butyric aldehyde, phenylacetic aldehyde, p-nitrobenzoic aldehyde and isovaleric aldehyde, followed by the synthesis of hydrobromide salts of 1-aminoalkylphosphonate diaryl esters, in which the benzyloxycarbonyl (Cbz) protective group is removed, and in the next step is reacted with an amino acid containing protected α-amino group in the presence of a coupling reagent. The resulting phosphonic dipeptide containing tert-butoxycarbonyl (t-Boc) protective group is subjected to deprotection of α-amino group and obtained dipeptidyl 1-aminoalkylphosphonate diaryl ester is coupled with another amino acid with protected α-amino group, biotin or a derivative thereof in a manner analogous to that described above.

专利号:US-2011172437-A1
优先权日:2008-04-01
标题:Perfluorophthalocyanine Molecules and Methods of Synthesis
发明人:GORUN SERGIU M; GERDES ROBERT; GERDES OLGA; LAPOK LUKASZ
权利人:NEW JERSEY TECH INST
摘要:Advantageous methods for synthesis of fluorinated phthalocyanines are provided. Typical implementation involves a reaction mixture that includes perfluoro compound that is reacted for a reaction period sufficient to yield a fluorinated phthalocyanine of formula F 64 PcM, wherein “Pcâ€? is any phthalocyanine macrocycle and “Mâ€? is hydrogen. Novel fluorinated phthalocyanine molecules/compounds are also provided herein, including specifically compounds that include fluorinated phthalocyanines wherein “Mâ€? is Cu or Vâ•?O. The fluorinated phthalocyanines have wide ranging applications, e.g., corrosion-related applications, coating-related applications, catalysis, and the production of optical and electronic materials.
福建永晶科技股份有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.yongjingtechnology.com
企业联系电话:0599-6200166👤
📞福建永晶科技股份有限公司 ⚠️参考联系方式
联系人:销售部
电话:0599-6200166
手机:18039722113
传真:0599-6616888
邮箱:sales@yongjingtech.cn
通信地址: 福建省邵武市金塘工业园区金岭大道6号
邮编: 354001
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:福建省邵武市金塘工业园区金岭大道6号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
上海瀚扬化工产品有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.hanyang-chem.com
企业联系电话:18063581547(微信同号);13310625905宓经理👤
📞上海瀚扬化工产品有限公司 ⚠️参考联系方式
联系人:宓经理
电话:18063581547(微信同号);13310625905宓经理
手机:18063581547(微信同号);13310625905

邮箱:3547229838@qq.com
通信地址: (上海)自由贸易试验区泰谷路169号A座一层113室
邮编:
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:(上海)自由贸易试验区泰谷路169号A座一层113室
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
山东洛恒化工产品有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.luohengchem.com
企业联系电话:18953927278(微信同号);16510354444👤
📞山东洛恒化工产品有限公司 ⚠️参考联系方式
联系人:成经理
电话:18953927278(微信同号);16510354444
手机:18953927278;16510354444
传真:QQ:412139239
邮箱:412139239@qq.com
通信地址: 山东聊城东昌府区光岳北路与财干路交叉口东南角别墅区51栋
邮编:
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:山东聊城东昌府区光岳北路与财干路交叉口东南角别墅区51栋
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
江苏宇田医药股份有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.jsytsw.com
企业联系电话:0518-86098000;86098017👤
📞江苏宇田医药股份有限公司 ⚠️参考联系方式
联系人:王先生;樊女士
电话:0518-86098000;86098017
手机:15261372765;18861350683

邮箱:sales@jsytsw.com
通信地址: 江苏连云港市经济技术开发区大浦工业区临浦路22号
邮编: 222000
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:江苏连云港市经济技术开发区大浦工业区临浦路22号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Hauben M, Hung EY, Hanretta KC, Bangalore S, Snow V. Safety of Perflutren Ultrasound Contrast Agents: A Disproportionality Analysis of the US FAERS Database. Drug Saf. 2015 Nov;38(11):1127-39. doi: 10.1007/s40264-015-0332-6. doi: 10.1111/echo.12971. doi: 10.1186/s40635-016-0079-0. Epub 2016 Mar 11.
4: Platts DG, Diab S, Dunster KR, Shekar K, Burstow DJ, Sim B, Tunbridge M, McDonald C, Chemonges S, Chan J, Fraser JF. Feasibility of perflutren microsphere contrast transthoracic echocardiography in the visualization of ventricular endocardium during venovenous extracorporeal membrane oxygenation in a validated ovine model. Echocardiography. 2015 Mar;32(3):548-56. doi: 10.1111/echo.12695. Epub 2014 Jul 24. doi: 10.1016/j.jcmg.2013.11.003. doi: 10.1016/j.hlc.2013.05.637. Epub 2013 Jun 10. doi: 10.1111/echo.12149. Epub 2013 Feb 22. doi: 10.1159/000338731. Epub 2012 Jul 18. doi: 10.1111/j.1540-8175.2011.01420.x. Epub 2011 May 12. doi: 10.1016/j.gie.2010.09.014.

合成参考文献


参考文献:10.1007/s00417-009-1236-x
摘要:Weichel ED, Bower KS, Colyer MH. Chorioretinectomy for perforating or severe intraocular foreign body injuries. Graefe's Archive for Clinical and Experimental Ophthalmology. 2009 Nov 22;248(3):319–30. doi: 10.1007/s00417-009-1236-x.
参考文献:10.1007/s11239-010-0450-z
摘要:Hua X, Liu P, Gao YH, Tan KB, Zhou LN, Liu Z, Li X, Zhou SW, Gao YJ. Construction of thrombus-targeted microbubbles carrying tissue plasminogen activator and their in vitro thrombolysis efficacy: a primary research. J Thromb Thrombolysis. 2010 Jul;30(1):29–35. doi: 10.1007/s11239-010-0450-z.
参考文献:10.1007/s11239-010-0448-6
摘要:Schwalm JR, Ahmad M, Salehian O, Eikelboom JW, Natarajan MK. Warfarin after anterior myocardial infarction in current era of dual antiplatelet therapy: a randomized feasibility trial. Journal of Thrombosis and Thrombolysis. 2010 Feb 16;30(2):127–32. doi: 10.1007/s11239-010-0448-6.
参考文献:10.2174/1874205x01105010055
摘要:Woods SD, Flores R, Roberson PK, Lowery JD, Skinner RD, Culp WC. Decreased Serum Levels of S-100B Protein Reflect Successful Treatment Effects in a Rabbit Model of Acute Ischemic Stroke. TONEUJ. 2011 Jun 21;05(1):55–7. doi: 10.2174/1874205x01105010055.
参考文献:10.1016/j.ophtha.2011.03.040
摘要:Sharma N, Mannan R, Jhanji V, Agarwal T, Pruthi A, Titiyal JS, Vajpayee RB. Ultrasound biomicroscopy-guided assessment of acute corneal hydrops. Ophthalmology. 2011 Nov;118(11):2166–71. doi: 10.1016/j.ophtha.2011.03.040.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知